News

Lunaphore launches the 2023 SPYRE™ Immuno-Oncology Grant Program, open to all discovery and translational labs in the field of Immuno-Oncology (IO)

Lunaphore expands its COMET™ portfolio to become the first universal, end-to-end spatial biology solution

Lunaphore raises CHF40M in the first close of Series D funding led by EGS Beteiligungen AG

Lunaphore will reveal new product releases and data at the AACR Annual Meeting 2023

Lunaphore expands flexible spatial biology offering with the launch of secondary antibodies for COMET™

Lunaphore and CRO Sirona Dx collaborate to expand COMET™ offerings to US-based biotech and biopharma customers

Lunaphore announces the winner of the 2022 COMET™ Grant Program

Lunaphore announces new data highlighting broad clinical potential of COMET™ platform at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Lunaphore announces new data with multiple research collaborators highlighting both the COMET™ platform and LabSat® instrument at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting